Payami, Babak, et al. “Amiodarone Can Still Be a Drug of Choice at Emergency Departments for Pre-Excited Atrial Fibrillation Even in the Face of Guidelines Prohibition”. Journal of Practical Emergency Medicine, vol. 10, no. 1, May 2023, p. e8, doi:10.22037/jpem.v10i1.40732.